相关实验视频
Updated: Jun 3, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
阿莱克提尼布HCl的固体分散:为改善生物可用性和建立IVIVC模型进行临床前评估
Sumit Kumar Saha1,2, Vipin Arya3, Ajinkya Jadhav4
1Department of Pharmacology, School of Pharmaceutical Education & Research, New Delhi, India.
阿莱克提尼布HCl固体分散配方在老鼠中改善了口服生物可用性. 一个体外-体内-活体相关性模型被开发来预测药物性能,帮助未来的临床评估.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 药理动力学 药理动力学
背景情况:
- 阿莱克提尼布HCl (ALB-HCl) 具有较低的可溶性和口服生物利用性 (BCS 第四类).
- 目前的高剂量建议与食物限制治疗潜力.
- 改善药物输送对于ALB-HCl疗效至关重要.
研究的目的:
- 开发和评估ALB-HCl.的固体分散 (SD) 配方.
- 建立一个体外-体外相关性 (IVIVC) 来预测生物可用性.
- 评估开发的配方的稳定性.
主要方法:
- 准备了三种SD配方,并对体外溶解进行了测试.
- 在Wistar大鼠中进行了体内药理动力学 (PK) 研究.
- 使用溶解和PK数据开发了一个IVIVC模型.
主要成果:
- 与单独使用API相比,无形SD配方 (II和III) 显著提高了Cmax和AUC0-last.
- 为Cmax和AUC0-last建立了一种A级IVIVC模型,可接受的预测误差.
- 在储存期间,ASD配方表现出良好的稳定性.
结论:
- 成功开发了一种稳定的无形固体分散 (ASD) 配方的ALB-HCl,提高了生物可用性.
- 一个IVIVC模型是预测体内性能的一个有价值的工具.
- 辅助剂的合理选择对于ASD配方的生物可用性和稳定性至关重要.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...